Breathprints of childhood obesity: changes in volatile organic compounds in obese children compared with lean controls
- PMID: 24677760
- PMCID: PMC4177515
- DOI: 10.1111/j.2047-6310.2014.221.x
Breathprints of childhood obesity: changes in volatile organic compounds in obese children compared with lean controls
Abstract
Objective: The objective of this study was to investigate changes in volatile organic compounds (VOCs) in exhaled breath in overweight/obese children compared with their lean counterparts.
Study design: Single exhaled breath was collected and analyzed per protocol using selective ion flow tube mass spectrometry (SIFT-MS).
Results: Sixty overweight/obese children and 55 lean controls were included. Compared with the lean group, the obese group was significantly older (14.1 ± 2.8 vs. 12.1 ± 3.0 years), taller (164.8 ± 10.9 vs. 153.3 ± 17.1 cm) and more likely to be Caucasian (60% vs. 35.2%); P < 0.05 for all. A comparison of the SIFT-MS results of the obese group with the lean group revealed differences in concentration of more than 50 compounds. A panel of four VOCs can identify the presence of overweight/obesity with excellent accuracy. Further analysis revealed that breath isoprene, 1-decene, 1-octene, ammonia and hydrogen sulfide were significantly higher in the obese group compared with the lean group (P value < 0.01 for all).
Conclusion: Obese children have a unique pattern of exhaled VOCs. Changes in VOCs observed in this study may help to gain insight into pathophysiological processes and pathways leading to the development of childhood obesity.
Keywords: Biomarker; breath testing; insulin resistance; oxidative stress.
© 2014 The Authors. Pediatric Obesity © 2014 International Association for the Study of Obesity.
Conflict of interest statement
Figures
Similar articles
-
Analysis of breath volatile organic compounds as a noninvasive tool to diagnose nonalcoholic fatty liver disease in children.Eur J Gastroenterol Hepatol. 2014 Jan;26(1):82-7. doi: 10.1097/MEG.0b013e3283650669. Eur J Gastroenterol Hepatol. 2014. PMID: 24284369
-
Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel disease: a pilot study.Aliment Pharmacol Ther. 2014 Sep;40(5):498-507. doi: 10.1111/apt.12861. Epub 2014 Jul 16. Aliment Pharmacol Ther. 2014. PMID: 25041596 Free PMC article.
-
Analysis of breath volatile organic compounds in children with chronic liver disease compared to healthy controls.J Breath Res. 2015 Apr 20;9(2):026002. doi: 10.1088/1752-7155/9/2/026002. J Breath Res. 2015. PMID: 25891513
-
Breathomics from exhaled volatile organic compounds in pediatric asthma.Pediatr Pulmonol. 2017 Dec;52(12):1616-1627. doi: 10.1002/ppul.23785. Epub 2017 Oct 30. Pediatr Pulmonol. 2017. PMID: 29082668 Review.
-
Exhaled breath testing - A tool for the clinician and researcher.Paediatr Respir Rev. 2019 Feb;29:37-41. doi: 10.1016/j.prrv.2018.05.002. Epub 2018 May 17. Paediatr Respir Rev. 2019. PMID: 29921519 Review.
Cited by
-
Gas chromatography-mass spectrometry pilot study to identify volatile organic compound biomarkers of childhood obesity with dyslipidemia in exhaled breath.J Transl Int Med. 2023 Mar 28;11(1):81-89. doi: 10.2478/jtim-2022-0035. eCollection 2023 Mar. J Transl Int Med. 2023. PMID: 37223613 Free PMC article.
-
Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease.JHEP Rep. 2020 Jun 15;2(5):100137. doi: 10.1016/j.jhepr.2020.100137. eCollection 2020 Oct. JHEP Rep. 2020. PMID: 32775974 Free PMC article.
-
Codium fragile Ameliorates High-Fat Diet-Induced Metabolism by Modulating the Gut Microbiota in Mice.Nutrients. 2020 Jun 21;12(6):1848. doi: 10.3390/nu12061848. Nutrients. 2020. PMID: 32575855 Free PMC article.
-
Development of severe bronchopulmonary dysplasia is associated with alterations in fecal volatile organic compounds.Pediatr Res. 2018 Feb;83(2):412-419. doi: 10.1038/pr.2017.268. Epub 2017 Nov 22. Pediatr Res. 2018. PMID: 29053703
-
Interplay Between the Intestinal Microbiota and Acute Graft-Versus-Host Disease: Experimental Evidence and Clinical Significance.Front Immunol. 2021 Mar 16;12:644982. doi: 10.3389/fimmu.2021.644982. eCollection 2021. Front Immunol. 2021. PMID: 33815399 Free PMC article. Review.
References
-
- Kim JY, Park JY, Kim OY, Ham BM, Kim HJ, Kwon DY, Jang Y, et al. Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS) J Proteome Res. 2010;9:4368–4375. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical